Home > Insider Trading > Filing (0001209191-19-043642)

Filing Details

Accession Number:: 0001209191-19-043642
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-07-30 15:57:52
Reporting Period:: 2019-07-26

Accepted Time:: 2019-07-30 15:57:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1645113	Novocure Ltd	NVCR	Surgical & Medical Instruments & Apparatus (3841)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1744884	Pritesh Shah	C/O Novocure Inc., 20 Valley Stream Parkway, Suite 300 Malvern PA 19355	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2019-07-26	12,500	$19.25	89,476	No	4	M	Direct
Ordinary Shares	Disposition	2019-07-26	578	$75.04	88,898	No	4	S	Direct
Ordinary Shares	Disposition	2019-07-26	2,710	$76.39	86,188	No	4	S	Direct
Ordinary Shares	Disposition	2019-07-26	2,800	$77.28	83,388	No	4	S	Direct
Ordinary Shares	Disposition	2019-07-26	2,455	$78.68	80,933	No	4	S	Direct
Ordinary Shares	Disposition	2019-07-26	3,857	$79.41	77,076	No	4	S	Direct
Ordinary Shares	Disposition	2019-07-26	100	$80.06	76,976	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Options To Buy Ordinary Shares	Options to buy Ordinary Shares	Acquisiton	2019-07-26	12,500	$0.00	12,500	$19.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,000		2027-07-25	No	4	M	Direct

Footnotes

These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.
On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $74.80 to $75.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $75.86 to $76.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $76.88 to $77.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $77.94 to $78.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $78.97 to $79.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Fully vested as of the date hereof.